Last reviewed · How we verify
NCT03173586
Sugar Sweetened Beverage Intake and Biomarkers of Cardiometabolic Risk in US Women
trial testing Sugar sweetened beverage (SSB) in Biomarkers in 33,000 participants. Completed in 31 March 2009.
31 March 2009
Quick facts
| Lead sponsor | Harvard School of Public Health (HSPH) |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 33,000 |
| Start date | 16 September 1999 |
| Primary completion | 31 March 2009 |
| Estimated completion | 31 March 2009 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Sugar sweetened beverage (SSB)
Conditions studied
- Biomarkers — all drugs for Biomarkers →
Sponsor
Harvard School of Public Health (HSPH)
Who can join
Adults 30 to 55, female only, with Biomarkers. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a secondary analysis of data collected in the Nurses' Health Study (NHS) that will evaluat the association between intake of sugar sweetened beverages (SSB), juice and artificially sweetened beverages in relation to biomarkers of hepatic function, lipid metabolism, inflammation and glycemic control.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03173586
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Biomarkers
Currently open trials in the same condition.
- NCT07012759 — Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients · recruiting
- NCT06717243 — Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS) · recruiting
- NCT06924372 — Application of Salivary Biomarkers in Risk Assessment for Oral Diseases in Children With Type 1 Diabetes · active not recruiting
- NCT07345286 — Clinical Aspects, Management and Surveillance of Febrile Illnesses in DRC · recruiting
- NCT06751251 — The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis Determi · active not recruiting
Other Harvard School of Public Health (HSPH) trials
Trials by the same sponsor.
- NCT07493772 — Multiple Micronutrient Supplementation With Digital Layering Among Adolescents in Tanzania · NA · not yet recruiting
- NCT06982339 — Beat the Heat Boston · NA · recruiting
- NCT06765863 — LIFT-UP: Randomized Controlled Trial of Fortification of Human Milk · NA · recruiting
- NCT06102044 — Zinc Supplementation for Young Infants With Clinical Severe Infection in Tanzania · Phase 3 · recruiting
- NCT06390943 — Low Birthweight and Preterm Infant Feeding Trial and Supportive Care Package: Implementation Research · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03173586 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Harvard School of Public Health (HSPH)
- Last refreshed: 2 June 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03173586.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing